These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6370875

  • 1. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB, Corrocher R, De Sandre G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):167-9. PubMed ID: 6370875
    [Abstract] [Full Text] [Related]

  • 2. Position of ceftazidime in respiratory diseases.
    Ando' F, Girbino G, Ferrara F.
    Drugs Exp Clin Res; 1985 Mar; 11(6):369-72. PubMed ID: 3915288
    [Abstract] [Full Text] [Related]

  • 3. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR.
    Clin Pharm; 1984 Mar; 3(4):373-85. PubMed ID: 6380902
    [Abstract] [Full Text] [Related]

  • 4. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A.
    Minerva Med; 1998 Mar; 89(1-2):15-22. PubMed ID: 9561021
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Mar; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 6. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA.
    Am J Hosp Pharm; 1994 Feb 15; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [Abstract] [Full Text] [Related]

  • 7. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
    Poletti T, Bertola D, Pellerito R, Soragna A.
    Minerva Med; 1980 Jul 15; 71(27):1935-43. PubMed ID: 6248823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 15; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ceftazidime--a new extended-spectrum cephalosporin.
    Gozzard DI, Geddes AM, Farrell ID, Eykyn SJ, Phillips I, Wise R, Brown RM.
    Lancet; 1982 May 22; 1(8282):1152-6. PubMed ID: 6122940
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients.
    Sheng WH, Wang JT, Chang SC.
    J Microbiol Immunol Infect; 2000 Jun 22; 33(2):109-14. PubMed ID: 10917881
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity.
    Harper PB.
    Clin Ther; 1984 Jun 22; 6(4):411-24. PubMed ID: 6432324
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.